Proton beam therapy shows promise in tumor control trial

NCT ID NCT06340815

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested the Varian ProBeam proton therapy system in 47 people with solid tumors. The goal was to see if the device safely controls tumors and meets performance standards. Patients received proton radiation and were followed for up to 5 years after treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Proton therapy (ProBeam system)

What this could lead to

If successful, this could support approval of a precise proton therapy system that targets tumors while sparing healthy tissue.

What could go wrong

This is a small, single-center study with no comparison group. Results may not apply to all tumor types or patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TUMOR, SOLID are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

benign neoplasm of brain brain cancer head and neck cancer neoplasm spinal cord cancer thoracic cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Shandong Cancer Hospital

    Jinan, Shandong, China